|
Jun 10
|
Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor
|
|
Jun 10
|
3 Reasons to Sell TNDM and 1 Stock to Buy Instead
|
|
Apr 15
|
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks
|
|
Apr 12
|
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction
|
|
Mar 20
|
Tandem announces publication of results from trial of Control-IQ+ AID technology
|
|
Mar 20
|
Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data
|
|
Mar 19
|
Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes
|
|
Mar 19
|
TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology
|
|
Mar 18
|
Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States
|
|
Mar 18
|
3 Healthcare Stocks Walking a Fine Line
|
|
Mar 11
|
Reasons to Hold TNDM Stock in Your Portfolio for Now
|
|
Feb 13
|
Tandem Diabetes Care Announces Upcoming Conference Presentations
|